| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Public Health and Clinical Medicine, Umeå University Hospital, Umeå, Sweden. * To whom correspondence should be addressed. E-mail: paul.franks{at}medicin.umu.se.
Related Article:
Metabolic Syndrome and Early Death. Getting to the Heart of the Problem
Paul W. Franks* and Tommy Olsson
Hypertension 2007 49: 40-47.
This article has been cited by other articles:
![]() |
C. Schindler Review: The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis? Therapeutic Advances in Cardiovascular Disease, October 1, 2007; 1(1): 7 - 26. [Abstract] [PDF] |
||||
![]() |
S. Colagiuri, C. M.Y. Lee, R. Huxley, and M. Woodward Metabolic Syndrome and Early Death Hypertension, July 1, 2007; 50(1): e5 - e5. [Full Text] [PDF] |
||||
![]() |
P. W. Franks and T. Olsson Response to Metabolic Syndrome and Early Death: Extending the Discussion on Heterogeneity Hypertension, July 1, 2007; 50(1): e6 - e6. [Full Text] [PDF] |
||||
![]() |
V. Tikhonoff and E. Casiglia Metabolic syndrome: nothing more than a constellation? Eur. Heart J., April 1, 2007; 28(7): 780 - 781. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |